MINNEAPOLIS & SAN FRANCISCO--(BUSINESS WIRE)--Data presented today at Heart Rhythm 2008, the annual congress of the Heart Rhythm Society, shows that remote monitoring of pacemaker patients via the Medtronic CareLink® Network detected clinically actionable events (CAEs) more quickly than routine follow-up care of transtelephonic monitoring (TTM) and in-office visits. Medtronic Inc. (NYSE: MDT) sponsored the PREFER (Pacemaker Remote Follow-up Evaluation and Review) trial, which was presented today as a late breaking clinical trial by Bruce Wilkoff, M.D., Director of Cardiac Pacing and Tachyarrhythmia Devices, Department of Cardiovascular Medicine, Cleveland Clinic, and Professor of Medicine at Cleveland Clinic Lerner College of Medicine, Case Western Reserve University.
